Free Trial

Protara Therapeutics (TARA) SEC Filings & 10K Form

Protara Therapeutics logo
$3.14 -0.04 (-1.10%)
As of 03:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Protara Therapeutics SEC Filings

DateFilerForm TypeView
05/14/2025
11:13 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
05/12/2025
8:01 AM
Adage Capital Management, L.P. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
05/08/2025
7:05 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:10 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
7:47 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 424B7
04/28/2025
7:35 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
3:05 PM
Nicacio Leonardo Viana (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
3:10 PM
Nicacio Leonardo Viana (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
10:17 AM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Zummo Jacqueline (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
11:58 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
03/05/2025
7:07 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
7:16 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:40 PM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
5:24 PM
CITADEL ADVISORS LLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:23 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G
02/14/2025
5:31 AM
Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
8:30 AM
Adage Capital Management, L.P. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G
01/23/2025
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Fabbio Patrick (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:34 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:20 PM
Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:20 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:20 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:02 PM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Velan Capital Investment Management LP (Filed by)
Form SC 13G
12/11/2024
3:19 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
6:30 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 424B5
12/09/2024
3:17 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 424B5
12/05/2024
7:45 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
5:01 AM
Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SC 13G
11/14/2024
11:19 AM
CVI Investments, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SC 13G/A
09/12/2024
7:20 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
6:11 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:16 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/18/2024
3:05 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
6:56 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:00 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
5:45 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
BESHAR LUKE M (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
06/10/2024
5:00 PM
GARCEAU ROGER (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Huang Jane (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Levy Richard S (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
SARGEN GREGORY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Solomon Michael Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Flannelly Barry P (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:01 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TARA) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners